The concept of SMARTool project
SMARTool project aims to develop a platform based on cloud technology for clinical decision support to the management of patients with coronary artery disease (CAD).
To integrate a site-specific model of plaque assessment/progression and a patient-specific risk stratification model and treatment tools into a unified platform to create a novel CDSS for patient management.
SMARTool final press release
Your inputs are important to support us designing the most suitable solution considering final users' needs and requirements.
SMARTool project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme, under the Grant Agreement number 689068.
This website reflects only the author's view. The Commission is not responsible for any use that may be made of the information it contains.
The aim of SMARTool
SMARTool aims at developing a platform comprising patient-specific and site specific models which are combined at several clinically relevant levels in order to deploy a novel CDSS which impacts on primary and secondary prevention of CHD, related to coronary plaque onset and progression. The heterogeneous data collected will include both imaging data (CCTA) and clinical, molecular and cellular data. Multiscale and multilevels models will integrate these data to obtain a CAD stratification model for diagnosis, CAD progression prediction model for prognosis and a CAD treatment model for therapeutical/interventional treatment. The final CDSS can be applied in primary and secondary prevention of CAD related CHD.
Meet the Coordination Team
SMARTool aims to carry out a multidisciplinary approach, involving cardiologists, clinical imaging experts, biologists, chemists, policy makers, engineers, health economists, data mining experts and bioinformaticians